M. Narazaki

Immunology · 2014–2019

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Narazaki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. T. Kishimoto

Papers from M. Narazaki's perspective

Ordered by how strongly the researchers M. Narazaki trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system (Nature Immunology)
  2. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells (Nature)
  3. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages (Nature Immunology)
  4. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. (Journal of Clinical Investigation)
  5. Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
  6. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury (Cell)
  7. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (New England Journal of Medicine)
  8. HMGB1 and RAGE in inflammation and cancer. (Annual Review of Immunology)
  9. Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury (Nature)
  10. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with… (Blood)

Their papers